Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6235683rdf:typepubmed:Citationlld:pubmed
pubmed-article:6235683lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6235683lifeskim:mentionsumls-concept:C0013072lld:lifeskim
pubmed-article:6235683lifeskim:mentionsumls-concept:C0001144lld:lifeskim
pubmed-article:6235683lifeskim:mentionsumls-concept:C0005088lld:lifeskim
pubmed-article:6235683lifeskim:mentionsumls-concept:C0025942lld:lifeskim
pubmed-article:6235683lifeskim:mentionsumls-concept:C0040845lld:lifeskim
pubmed-article:6235683lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:6235683pubmed:issue13lld:pubmed
pubmed-article:6235683pubmed:dateCreated1984-9-19lld:pubmed
pubmed-article:6235683pubmed:abstractTextThe clinical efficacy and tolerance of a combination of benzoyl peroxide 5% and miconazole 2%, Acnidazil, for the treatment of facial acne vulgaris have been compared with those of tretinoin 0.05% in a double-blind study with 40 patients during 12 weeks. The combination of benzoyl peroxide and miconazole gave improvement in 82% of 22 patients, compared to tretinoin which gave improvement in 50% of 18 comparable patients. The difference is significant. Also, side-effects were significantly less in the benzoyl-miconazole group than in the tretinoin group.lld:pubmed
pubmed-article:6235683pubmed:languagegerlld:pubmed
pubmed-article:6235683pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6235683pubmed:citationSubsetIMlld:pubmed
pubmed-article:6235683pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6235683pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6235683pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6235683pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6235683pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6235683pubmed:statusMEDLINElld:pubmed
pubmed-article:6235683pubmed:monthJullld:pubmed
pubmed-article:6235683pubmed:issn0301-0481lld:pubmed
pubmed-article:6235683pubmed:authorpubmed-author:VoldenGGlld:pubmed
pubmed-article:6235683pubmed:authorpubmed-author:FalkE SESlld:pubmed
pubmed-article:6235683pubmed:authorpubmed-author:KavliGGlld:pubmed
pubmed-article:6235683pubmed:authorpubmed-author:StenvoldS ESElld:pubmed
pubmed-article:6235683pubmed:authorpubmed-author:MosengDDlld:pubmed
pubmed-article:6235683pubmed:authorpubmed-author:MidelfartKKlld:pubmed
pubmed-article:6235683pubmed:authorpubmed-author:LaastadOOlld:pubmed
pubmed-article:6235683pubmed:authorpubmed-author:NilsenJ WJWlld:pubmed
pubmed-article:6235683pubmed:issnTypePrintlld:pubmed
pubmed-article:6235683pubmed:day1lld:pubmed
pubmed-article:6235683pubmed:volume59lld:pubmed
pubmed-article:6235683pubmed:ownerNLMlld:pubmed
pubmed-article:6235683pubmed:authorsCompleteYlld:pubmed
pubmed-article:6235683pubmed:pagination882-7lld:pubmed
pubmed-article:6235683pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:meshHeadingpubmed-meshheading:6235683-...lld:pubmed
pubmed-article:6235683pubmed:year1984lld:pubmed
pubmed-article:6235683pubmed:articleTitle[Treatment of acne vulgaris. Double-blind study of a combination of 5% benzoyl peroxide/2% miconazole (Acnidazil) and tretinoin 0.05%].lld:pubmed
pubmed-article:6235683pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6235683pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:6235683pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6235683pubmed:publicationTypeEnglish Abstractlld:pubmed